Email this article 
Pharmaceutical industry in Russia: problems and prospects of development
- Authors: Nezhnikova E.V.1, Maksimchuk M.V.1
-
Affiliations:
- Peoples’ Friendship University of Russia (RUDN University)
- Issue: Vol 27, No 1 (2019)
- Pages: 102-112
- Section: INDUSTRIAL ORGANIZATION MARKETS
- URL: https://journals.rudn.ru/economics/article/view/21304
- DOI: https://doi.org/10.22363/2313-2329-2019-27-1-102-112
Cite item
Full Text
Abstract
The paper analyzes the changes in the Russian pharmaceutical market and discusses the prospects and trends of the Russian pharmaceutical industry. The purpose of the work is to identify the main directions and problems of development and functioning of the pharmaceutical industry of the Russian Federation. Over the past few years, the state has created a strategy for the development of pharmaceuticals, which can bring the industry to a new level. However, existing problems and the lack of an integrated approach hamper the fulfillment of this task. Based on the analysis, the author provides a list of recommendations to improve the efficiency of the functioning and solving the main problems of the pharmaceutical industry, special attention is paid to increasing the investment potential, strengthening the legal framework of the industry, and the importance of increasing the innovative potential of the industry.
About the authors
Ekaterina V. Nezhnikova
Peoples’ Friendship University of Russia (RUDN University)
Author for correspondence.
Email: katnej@mail.ru
Dr. Sci (Econ.), Associate Professor
6 Miklukho-Maklaya St., Moscow, 117198, Russian FederationMaksim V. Maksimchuk
Peoples’ Friendship University of Russia (RUDN University)
Email: 1032176158@pfur.ru
postgraduate student, Department of National Economics
6 Miklukho-Maklaya St., Moscow, 117198, Russian FederationReferences
- Aleksandr L. (2018). Farmotrasli nuzhny gormony rosta [Pharmaceuticals need growth hormones]. Ehkspert, 21(1075), 39-41. (In Russ.)
- Balashov A.I. (2012). Formirovanie mekhanizma ustojchivogo razvitiya farmacevticheskoj otrasli: teoriya i metodologiya [Formation of the mechanism of sustainable development of the pharmaceutical industry: theory and methodology]. Saint Petersburg: SPbGUEHF Publ., 161. (In Russ.)
- Danilov A.I., Asriev S.A., Lavrova E.V. (2017). Programma importozameshcheniya v oblasti lekarstvennogo obespecheniya naseleniya Rossijskoj Federacii [The program of import substitution in the field of drug supply of the population of the Russian Federation]. Vestnik Smolenskoj gosudarstvennoy medicinskoy akademii, (4), 114-120. (In Russ.)
- DSM Group Marketing Agency. http://dsm.ru/ (accessed: 05.09.2018).
- Kostromin P.A. (2014). Razvitie farmacevticheskih predpriyatiy: metodologiya, instrumenty, ehffektivnost’ [Development of pharmaceutical enterprises: methodology, tools, efficiency]. Teoriya i praktika obshchestvennogo razvitiya, (6), 151-154. (In Russ.)
- Kvachahiya L.L. (2017). Politika importozameshcheniya na otechestvennom farmacevticheskom rynke [Import substitution policy in the domestic pharmaceutical market]. Innov, 4(33), 31-40. (In Russ.)
- Nezhnikova E.V. (2018). Teoreticheskie i prakticheskie aspekty planirovaniya konkurentosposobnosti i kachestva produkcii organizacij v rynochnoj srede [Theoretical and practical aspects of planning competitiveness and quality of products of organizations in a market environment]. Ekonomika i predprinimatel’stvo, 2(90-2). (In Russ.)
- Pharma 2020: From Vision to Decision. http://www.pwc.com/gx/en/pharma-life-sciences/ pharma2020/assets/pwc-pharma-success-strategies.pdf (accessed: 07.09.2018).
- Romanova S.A. (2017). Pharmaceutical industry for 9 months 2017. Remedium, (11-12), 52-56.
- Volodin S.N., Zueva E.S. (2017). Rossijskaya farmacevticheskaya otrasl’: investicionnaya privlekatel’nost’, riski i perspektivy razvitiya [Russian pharmaceutical industry: investment attractiveness, risks and development prospects]. Upravlencheskij uchet i finansy, (2), 96-107. (In Russ.)
- Zaur A.M. (2017). Tendencii i perspektivy rossijskoy farmacevticheskoy otrasli i primenimost’ mirovogo opyta [Trends and prospects of the Russian pharmaceutical industry and the applicability of international experience]. MIR (Modernizaciya. Innovacii. Razvitie), (4), 772-780. (In Russ.)
